Author Archive: Jeremy Parkinson
2007 All Over Again, Part 4: “We Are Outsourcing Our Monetary Policy”
<< Read More: 2007 All Over Again? Let Us Count The Ways (And Remember What Happened Then) – Part 1 << Read More: 2007 All Over Again? Mega-Merger Edition – Part 2 <<Read more: 2007 All Over Again: Banks Starting To Implode – Part 3 In that deservedly-famous 2006 CNBC debate between Peter Schiff and economist Arthur Laffer (in […]
What This Week’s Federal Reserve Interest Rate News Means For Markets In 2016
Global stocks and commodities are rallying today (Wednesday) following the U.S.Federal Reserve interest rate announcement from Chair Janet Yellen yesterday. Yellen was extremely dovish in yesterday’s Federal Reserve interest rate statement, saying the central bank needs to remain cautious when hiking rates this year. The Fed has also cut the number of rate hikes it plans to hold […]
Crude Crashes Into Red Post-Yellen
Well, that escalated quickly… Gold is clinging to unch, bonds are down, and now crude has crashed back into the red post-Yellen… Only stocks remain positive – which makes perfect sense given Yellen’s implied downgrade of every positive economic indicator (and the 22.5x GAAP P/E).
Can Big Money Limit The Upside Potential For Facebook Stock?
123RF On the 4th of March, Eric Chemi announced on CNBC that Facebook (NASDAQ:FB) is now among the top 20 most widely held stocks. This is the first time that Facebook has made it on the top 20 list of the most held stocks among institutional equity investors. Facebook surged from a ranking of 23rd in September […]
Pfizer, Allergan Receive Request For Additional Information From FTC
Pfizer (PFE) and Allergan (AGN) announced that the companies have received a request for additional information from the U.S. Federal Trade Commission with respect to their previously announced pending combination. The request for information from the FTC, often referred to as a “second request,” was fully anticipated as part of the regulatory process under the […]
To Money Or Not Money, That Is The Question
When former Dallas Fed President Richard Fisher stepped down last March after a decade in that role, the New York Times (of course) wrote his professional obituary under the headline Richard Fisher, Often Wrong But Seldom Boring. Fisher had apparently viewed his own philosophical root and career at the Fed as something of an updated Paul […]
Tuning In To Trust & Ethics: Leadership At Barclays Bank
Organizations and their leaders often find themselves caught in “trust and ethics traps.” Jes Staley the newly appointed American CEO of the beleaguered British Barclays Bank is one such leader. In fact, as he recently announced in this BBC News Article “I do believe that trust is returning to our institution. But we will never rest, we […]
Apple V. FBI And Apple’s New Products On Fox 5
(Video length 00:03:58) Shelly Palmer talks about the Apple v. FBI case and things you need to know about the Apple Watch and Apple’s new iPhone SE and new iPad on Fox 5 with Ben Simmoneau and Juliet Huddy. Original Airdate: March 29, 2016
Acadia Pharmaceuticals: Nuplazid Gets Overwhelming Backing
Acadia Pharmaceuticals (ACAD 25.86 +2.06 8.63%) made it. The company’s New Drug Application (NDA) for Nuplazid was overwhelmingly backed by the advisory panel for approval. 12 members in the panel voted in favor of an approval while just 2 voted against it. Trading in ACAD shares was halted on Tuesday as the Ad Comm met to review the NDA. But […]
EC “You Want Another Hike? Already?”
I was surprised in December when the most dovish central banker ever to lead the Fed allowed the body to implement a tightening, so perhaps I shouldn’t be surprised now that she is staunchly resisting an increasingly-raucous chorus of hawks. Prior to the Fed’s last meeting, I noted that if there was ever an excuse for tightening, […]
